Sculptor Capital’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-4,470,121
Closed -$950M 901
2014
Q4
$950M Buy
4,470,121
+581,615
+15% +$116M 2.56% 1
2014
Q3
$693M Buy
3,888,506
+1,312,369
+51% +$218M 2% 3
2014
Q2
$436M Buy
2,576,137
+2,531,598
+5,684% +$394M 1.3% 14
2014
Q1
$5.53M Sell
44,539
-37,884
-46% -$4.61M 0.02% 485
2013
Q4
$9.16M Sell
82,423
-47,971
-37% -$4.58M 0.02% 470
2013
Q3
$11.8M Buy
130,394
+10,511
+9% +$944K 0.03% 428
2013
Q2
$10.1M Buy
+119,883
New +$12.4M 0.03% 422

Other funds holding AGN

Sculptor Capital's AGN Position: Q1 2015 in Review

Sculptor Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 4,470,121 shares — an estimated $950M sold.

Sculptor Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $950M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Sculptor Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Sculptor Capital sold 4,470,121 Allergan Inc shares in Q1 2015, an estimated $950M.
  • Sculptor Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Sculptor Capital's Allergan Inc position peaked at $950M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Sculptor Capital's 13F filing for Q1 2015, filed 15 May 2015.